Carvajal Alejandra
SEC insider (Form 3/4/5 filer). CIK 0001645755. Chief Legal Officer at CytomX Therapeutics, Inc. (CTMX) and 1 other issuer. 25 reported Form 4/5 transactions since Sep 2024; latest on Aug 3, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Carvajal Alejandra has filed insider reports for
- CytomX Therapeutics, Inc. (CTMX): Officer, Chief Legal Officer
- Mersana Therapeutics, Inc. (MRSN): Officer, SVP, Chief Legal Officer
Carvajal Alejandra
CIK: 0001645755
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (25 total)
- Aug 3, 2026CTMX
CytomX Therapeutics, Inc.
AwardDirect100K shares- - Jan 6, 2026MRSN
Mersana Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
1.1K shares- - Jan 6, 2026MRSN
Mersana Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
4.5K shares- - Jan 6, 2026MRSN
Mersana Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
1.5K shares- - Jan 6, 2026MRSN
Mersana Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
6.7K shares- - Jan 6, 2026MRSN
Mersana Therapeutics, Inc.
Tender OfferDirect3.1K shares- - Jan 6, 2026MRSN
Mersana Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
4.9K shares- - Jan 6, 2026MRSN
Mersana Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
3K shares- - Jan 6, 2026MRSN
Mersana Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
1.8K shares- - Jan 6, 2026MRSN
Mersana Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
7.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 3, 2026 |  CTMX CytomX Therapeutics, Inc. | Award | 100,000 | - | $0 | Direct |
| Jan 6, 2026 |  MRSN Mersana Therapeutics, Inc. | Disposition Stock Option (right to buy) | 1,078 | - | - | Direct |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc. | Disposition Stock Option (right to buy) | 4,500 | - | - | Direct |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc. | Disposition Stock Option (right to buy) | 1,527 | - | - | Direct |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc. | Disposition Stock Option (right to buy) | 6,702 | - | - | Direct |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc. | Tender Offer | 3,131 | - | $0 | Direct |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc. | Disposition Stock Option (right to buy) | 4,922 | - | - | Direct |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc. | Disposition Stock Option (right to buy) | 3,047 | - | - | Direct |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc. | Disposition Stock Option (right to buy) | 1,800 | - | - | Direct |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc. | Disposition Stock Option (right to buy) | 7,921 | - | - | Direct |
1-10 of 25 transactions